Wellington Management Group’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60M Sell
1,292,573
-49,251
-4% -$1.77M 0.01% 695
2026
Q1
$32.9M Buy
1,341,824
+602,971
+82% +$14.3M 0.01% 858
2025
Q4
$18.3M Buy
738,853
+596,293
+418% +$15.8M ﹤0.01% 1065
2025
Q3
$4.04M Buy
+142,560
New +$3.86M ﹤0.01% 1491
2022
Q4
Sell
-13,768
Closed -$537K 2136
2022
Q3
$537K Buy
+13,768
New +$630K ﹤0.01% 1783

Other funds holding ASTH

Wellington Management Group's ASTH Position: Q2 2026 in Review

Wellington Management Group reduced its Astrana Health (ASTH) stake by 3.7% in Q2 2026, selling an estimated $1.77M and leaving 1,292,573 shares worth $60M. The position accounts for 0.01% of the portfolio, ranked #695.

Wellington Management Group first reported a position in ASTH in Q3 2022 and has held it in 5 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Wellington Management Group held 1,292,573 shares of Astrana Health worth $60M as of Q2 2026.
  • Wellington Management Group sold 49,251 Astrana Health shares in Q2 2026, an estimated $1.77M.
  • Astrana Health made up 0.01% of Wellington Management Group's portfolio in Q2 2026, its #695 holding.
  • Wellington Management Group first reported a position in Astrana Health in Q3 2022 and has held it in 5 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.